Will Amgen say “Dazodalibep”?
Amgen said “Dazodalibep” 9 times on its Nov 3, 2026 call (FY26 Q3), and on 3 of its last 8 calls: 0, 0, 0, 0, 0, 3, 10, 9 times. As of Nov 11, 2026, Amgen said “Dazodalibep” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026. Parrot’s p for the next listing is 83% (n=1, from settlement history blended with transcripts), not a forecast.
- Last 10
- 1/1Last 10 settled, oldest to newest: yes
- Streak
- said last time
- Counts
- company speakers + operator
- Market
- 82¢ Kalshi (may be delayed)
Where it was said
quotes of at most 25 words; select an appearanceAmgen
Dazodalibep
- Probability
- 83% · n=1
- Settled
- 1/1 (100%)
- Last calls
- said in 3 of 8
Next listing counts: company speakers + operator
Counts: company speakers + operator
9 counted (7 in prepared remarks, 2 in Q&A).
…cornerstone therapy, TEZSPIRE in eosinophilic esophagitis, an area with significant unmet need, and dazodalibep in Sjögren's disease, where no approved disease-modifying therapies currently exist.
…diseases: IMDELLTRA in small cell lung cancer, TEZSPIRE in eosinophilic esophagitis, and dazodalibep in Sjögren's disease. These results reflect our R&D strategy that focuses on…
Counts: company speakers + operator (not listed here; the usual rule)
10 counted (3 in prepared remarks, 7 in Q&A); 2 by speakers the rule does not count.
…where we are focused on challenging and rare autoimmune diseases with UPLIZNA, dazodalibep, and blinatumomab. UPLIZNA has established the benefit of CD19-directed B-cell depletion in…
…in the U.S. For patients suffering from Sjögren's disease, we are developing dazodalibep. Dazodalibep targets CD40 ligand-mediated signaling between activated T cells and B cells…
Counts: company speakers + operator (not listed here; the usual rule)
3 counted (1 in prepared remarks, 2 in Q&A).
…improving convenience and expanding treatment options for patients with thyroid eye disease. Dazodalibep, our first-in-class CD40 ligand targeting fusion protein continues to progress with 2…
Every settled listing
newest first · 1 shown| Date | Listed as | Venue | Result | Our count |
|---|---|---|---|---|
| Nov 3, 2026 | Dazodalibep |  Kalshi | Yes | 9 |
Questions
- How many times did Amgen say “Dazodalibep” on its last earnings call?
- Amgen said “Dazodalibep” 9 times on its Nov 3, 2026 call (FY26 Q3), and on 3 of its last 8 calls: 0, 0, 0, 0, 0, 3, 10, 9 times.
- How often does Amgen say “Dazodalibep”?
- As of Nov 11, 2026, Amgen said “Dazodalibep” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026.
- What is the probability Amgen says “Dazodalibep” next time?
- 83%, from settlement history blended with transcripts (n=1). It is a base rate from history, not a forecast and not advice.
- Who has to say it for the market to count?
- Under the next market's rule: company speakers + operator.
Cite parrot.markets, “Amgen: ‘Dazodalibep’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/dazodalibep (CC BY 4.0)
Agents: this page as TSV at /api/v1/word?entity=amgen&word=dazodalibep · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP